FOR IMMEDIATE RELEASE
NOTICE OF PALADIN LAB'S FOURTH QUARTER AND YEAR-END RESULTS CONFERENCE CALL
Montreal, Canada, February 3, 2004 - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release financial results for its fourth quarter and year-end on Thursday, February 5, 2004 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EST) hosted by Jonathan Ross Goodman, President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.
CONFERENCE CALL DETAILS:
DATE: Thursday, February 5, 2004 TIME: 10:00 a.m. EST DIAL IN NUMBER: 1-800-273-9672 or 416-695-5806 REFERENCE NUMBER: 1526973 TAPED REPLAY: 1-800-408-3053 OR 416-695-5800
Available from Thursday, February 5th at noon until
Thursday, February 12th at midnight.The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com and www.financialdisclosure.ca.
About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Quebec, is a leading specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada’s leading specialty pharmaceutical companies. Paladin’s shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin web site at www.paladinlabs.com
For further information please contact:Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.comThe Equicom Group Inc.
Bruce Wigle
Investor Relations
Tel: 416-815-0700 ext.228
e-mail: bwigle@equicomgroup.com